Clinical Trial Update: Hemoglobin Maintenance in Pediatric ESRD (End-stage Renal Disease) Patients by Ferric Pyrophosphate Citrate (FPC) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update on ferric pyrophosphate citrate (FPC) for hemoglobin maintenance in pediatric patients with end-stage renal disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Ferric pyrophosphate citrate (ferric pyrophosphate citrate)

Snippet

Sponsor: Rockwell Medical Technologies, Inc. | Conditions: End Stage Renal Disease | Phase 3 | Status: UNKNOWN